These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30664120)

  • 21. Development of Stem Cell Therapies for Retinal Degeneration.
    West EL; Ribeiro J; Ali RR
    Cold Spring Harb Perspect Biol; 2020 Aug; 12(8):. PubMed ID: 31818854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optogenetic approaches to therapy for inherited retinal degenerations.
    De Silva SR; Moore AT
    J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic approaches for retinitis pigmentosa].
    Pach J; Gekeler F
    Klin Monbl Augenheilkd; 2013 May; 230(5):512-8. PubMed ID: 23695848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem/Progenitor Cells and Biodegradable Scaffolds in the Treatment of Retinal Degenerative Diseases.
    Wang Y; Zhang D; Shen B; Zhang Y; Gu P
    Curr Stem Cell Res Ther; 2018 Feb; 13(3):160-173. PubMed ID: 29284397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The functional characteristics of optogenetic gene therapy for vision restoration.
    Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
    Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting.
    Bovi Dos Santos G; de Lima-Vasconcellos TH; Móvio MI; Birbrair A; Del Debbio CB; Kihara AH
    Stem Cell Rev Rep; 2024 Apr; 20(3):722-737. PubMed ID: 38319527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects.
    Singh R; Cuzzani O; Binette F; Sternberg H; West MD; Nasonkin IO
    Stem Cell Rev Rep; 2018 Aug; 14(4):463-483. PubMed ID: 29675776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Layer-specific nanophotonic delivery of therapeutic opsin-encoding genes into retina.
    Batabyal S; Kim S; Wright W; Mohanty S
    Exp Eye Res; 2021 Apr; 205():108444. PubMed ID: 33516760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stem Cells for Retina Replacement].
    Seitz IP; Achberger K; Liebau S; Fischer MD
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1350-1356. PubMed ID: 27479580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel vision restoration techniques: 3D bioprinting, gene and stem cell therapy, optogenetics, and the bionic eye.
    Menon A; Vijayavenkataraman S
    Artif Organs; 2022 Aug; 46(8):1463-1474. PubMed ID: 35373344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.
    Zhao C; Wang Q; Temple S
    Development; 2017 Apr; 144(8):1368-1381. PubMed ID: 28400433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases.
    Yan B; Nirenberg S
    IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optogenetic Retinal Gene Therapy with the Light Gated GPCR Vertebrate Rhodopsin.
    Gaub BM; Berry MH; Visel M; Holt A; Isacoff EY; Flannery JG
    Methods Mol Biol; 2018; 1715():177-189. PubMed ID: 29188513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.
    Vázquez-Domínguez I; Garanto A; Collin RWJ
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31466352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology and therapeutic potential of adult retinal stem cells.
    Ballios BG; van der Kooy D
    Can J Ophthalmol; 2010 Aug; 45(4):342-51. PubMed ID: 20648091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
    Kralik J; Kleinlogel S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal Tissue Engineering: Regenerative and Drug Delivery Approaches.
    Aghmiuni AI; Keshel SH; Rahmani A; Nadri S; Sefat F; Lashay A
    Curr Stem Cell Res Ther; 2023; 18(5):608-640. PubMed ID: 35733318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.
    Di Foggia V; Makwana P; Ali RR; Sowden JC
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):240-52. PubMed ID: 27027805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing an Outcome Measure With High Luminance for Optogenetics Treatment of Severe Retinal Degenerations and for Gene Therapy of Cone Diseases.
    Cideciyan AV; Roman AJ; Jacobson SG; Yan B; Pascolini M; Charng J; Pajaro S; Nirenberg S
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3211-21. PubMed ID: 27309625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach.
    Gagliardi G; Ben M'Barek K; Goureau O
    Prog Retin Eye Res; 2019 Jul; 71():1-25. PubMed ID: 30885665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.